Skip to main content

Table 2 Median (range) HGF C max in phase 1 vs. phase 2, nadroparin group

From: Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications

HGF phase 1 vs. HGF phase 2

HGF phase 1

HGF phase 2

p

Cmax (ng/ml)

6.41 (0.75-7.38)

4.59 (2.75-6.25)

0.060

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us